+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Infectious Disease Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents), By Technology (PCR, ISH, INAAT), By End-use, By Application, By Region, And Segment Forecasts, 2021 - 2028

  • PDF Icon

    Report

  • 169 Pages
  • September 2021
  • Region: Global
  • Grand View Research
  • ID: 5440482
Description Jump to:
The global infectious disease molecular diagnostics market size is expected to reach USD 40.8 billion by 2028, according to a new report by the publisher. The market is estimated to expand at a CAGR of 3.0% from 2020 to 2028. The market is driven by the introduction of technologically advanced products and an increase in demand for molecular diagnostics in PoC settings.

Rapid technological advancements with portability, accurate results, and cost-effectiveness are anticipated to serve as crucial drivers of the market for infectious disease molecular diagnostics. Companies are upgrading their products by implementing new techniques to gain specific and accurate results. Key players are updating their product portfolio for PCR instruments with increased R&D initiatives for developing novel kits to target emerging diseases or by entering into agreements with other kit manufacturing companies.

Technologies such as INAAT, mass spectroscopy, and ISH are advanced and have a low false-positive rate as compared to other traditional diagnostic tests. Advantages such as the cost-effectiveness and user-friendliness of this technology and the accuracy offered are estimated to increase the adoption of this technology.

The use of molecular diagnostics in research institutes is increasing. The use of techniques such as PCR, western blotting, and southern blotting is becoming common. Moreover, the spread of SARS-CoV-2 infection globally has led to an increase in research funding by governments as well as diagnostic companies to search for innovative molecular diagnostics.

Molecular diagnostics deliver effective and accurate results. Moreover, these tests enable the early detection of diseases, maintaining a low threat of substitutes. However, the high prices of these tests are expected to encourage patients to shift to external substitutes. Moreover, for the detection of newer infections such as SARS-CoV-2, the rate of internal substitution is high, which boosts competitive rivalry.

Infectious Disease Molecular Diagnostics Market Report Highlights

  • The reagent segment is expected to exhibit the fastest growth rate attributable to increased adoption
  • The growing geriatric population in Asian countries, such as Japan and China, with high untapped opportunities is expected to drive the market for infectious disease molecular diagnostics in the region during the forecast period
  • The In Situ Hybridization (ISH) segment is anticipated to witness the fastest growth rate owing to high sensitivity and lower complexity
  • The high growth rate of the market for infectious disease molecular diagnostics in the Asia Pacific can be attributed to increased access to healthcare in the developing nations


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Regional scope
1.1.2 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased database:
1.3.2 Internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
Chapter 3 Infectious Disease Molecular Diagnostics Market Variables, Trends & Scope
3.1 Infectious Disease Molecular Diagnostics Market Lineage Outlook
3.1.1 Parent market outlook
3.2 User Perspective Analysis
3.3 Penetration & Growth Prospect Mapping
3.4 Regulatory and Reimbursement Framework
3.5 Market Dynamics
3.5.1 Market driver analysis
3.5.1.1 Increase in geriatric population
3.5.1.2 Introduction of technologically advanced products
3.5.1.3 Increase in demand for point-of-care Daignostics
3.5.1.4 Growing prevalence of target diseases
3.5.1.5 Increasing external funding for R&D
3.5.1.6 Outbreak of COVID-19
3.5.2 Market restraint analysis
3.5.2.1 Presence of ambiguous regulatory framework
3.5.2.2 High prices of Infectious Disease Molecular Diagnostics tests
3.6 Infectious Disease Molecular Diagnostics Market Analysis Tools
3.6.1 Porter’s Five Forces Analysis
3.6.2 SWOT Analysis; By factor (Political & Legal, Economic and Technological)
3.6.3 Major deals & strategic alliances analysis
3.6.3.1 New product launch
3.6.3.2 Mergers and acquisitions
3.6.3.3 Expansion
3.6.3.4 Partnerships
3.6.3.5 Market entry strategies
Chapter 4 Products Business Analysis
4.1 Infectious Disease Molecular Diagnostics Market: Products Movement Analysis
4.1.1 Instruments
4.1.1.1 Instruments market estimates and forecast, 2017 - 2028 (USD Million)
4.1.2 Reagents
4.1.2.1 Reagents market estimates and forecast, 2017 - 2028 (USD Million)
4.1.3 Services
4.1.3.1 Services market estimates and forecast, 2017 - 2028 (USD Million)
Chapter 5 Technology Business Analysis
5.1 Infectious Disease Molecular Diagnostics Market: Technology Movement Analysis
5.1.1 Polymerase Chain Reaction
5.1.1.1 Polymerase chain reaction market estimates and forecast, 2017 - 2028 (USD Million)
5.1.1.2 PCR Market by type
5.1.1.2.1 Multiplex PCR
5.1.1.2.1.1 Multiplex PCR market estimates and forecast, 2017 - 2028 (USD Million)
5.1.1.2.2 Other PCR
5.1.1.2.2.1 Other PCR market estimates and forecast, 2017 - 2028 (USD Million)
5.1.1.3 PCR market, by Product
5.1.1.3.1 Instruments
5.1.1.3.1.1 Instruments PCR market estimates and forecast, 2017 - 2028 (USD Million)
5.1.1.3.2 Reagents
5.1.1.3.2.1 Reagents PCR market estimates and forecast, 2017 - 2028 (USD Million)
5.1.1.3.3 Services
5.1.1.3.3.1 Services PCR market estimates and forecast, 2017 - 2028 (USD Million)
5.1.2 In Situ Hybridization (ISH)
5.1.2.1 In Situ Hybridization market estimates and forecast, 2017 - 2028 (USD Million)
5.1.2.2 Instruments
5.1.2.2.1 Instruments ISH market estimates and forecast, 2017 - 2028 (USD Million)
5.1.2.3 Reagents
5.1.2.3.1 Reagents ISH market estimates and forecast, 2017 - 2028 (USD Million)
5.1.2.4 Others
5.1.2.4.1 Others ISH market estimates and forecast, 2017 - 2028 (USD Million)
5.1.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
5.1.3.1 INAAT market estimates and forecast, 2017 - 2028 (USD Million)
5.1.3.2 Instruments
5.1.3.2.1 Instruments INAAT market estimates and forecast, 2017 - 2028 (USD Million)
5.1.3.3 Reagents
5.1.3.3.1 Reagents INAAT market estimates and forecast, 2017 - 2028 (USD Million)
5.1.3.4 Services
5.1.3.4.1 Services INAAT market estimates and forecast, 2017 - 2028 (USD Million)
5.1.4 Chips and Microarrays
5.1.4.1 Chips and Microarrays market estimates and forecast, 2017 - 2028 (USD Million)
5.1.4.2 Instruments
5.1.4.2.1 Instruments chips and microarrays market estimates and forecast, 2017 - 2028 (USD Million)
5.1.4.3 Reagents
5.1.4.3.1 Reagents chips and microarrays market estimates and forecast, 2017 - 2028 (USD Million)
5.1.4.4 Services
5.1.4.4.1 Services chips and microarrays market estimates and forecast, 2017 - 2028 (USD Million)
5.1.5 Mass Spectrometry
5.1.5.1 Mass Spectrometry market estimates and forecast, 2017 - 2028 (USD Million)
5.1.5.2 Instruments
5.1.5.2.1 Instruments mass spectrometry market estimates and forecast, 2017 - 2028 (USD Million)
5.1.5.3 Reagents
5.1.5.3.1 Reagents mass spectrometry market estimates and forecast, 2017 - 2028 (USD Million)
5.1.5.4 Services
5.1.5.4.1 Services mass spectrometry market estimates and forecast, 2017 - 2028 (USD Million)
5.1.6 Sequencing
5.1.6.1 Sequencing market estimates and forecast, 2017 - 2028 (USD Million)
5.1.6.2 Instruments
5.1.6.2.1 Instruments sequencing market estimates and forecast, 2017 - 2028 (USD Million)
5.1.6.3 Reagents
5.1.6.3.1 Reagents sequencing market estimates and forecast, 2017 - 2028 (USD Million)
5.1.6.4 Services
5.1.6.4.1 Services sequencing market estimates and forecast, 2017 - 2028 (USD Million)
5.1.7 Transcription Mediated Amplification (TMA)
5.1.7.1 TMA market estimates and forecast, 2017 - 2028 (USD Million)
5.1.7.2 Instruments
5.1.7.2.1 Instruments TMA market estimates and forecast, 2017 - 2028 (USD Million)
5.1.7.3 Reagents
5.1.7.3.1 Reagents TMA market estimates and forecast, 2017 - 2028 (USD Million)
5.1.7.4 Services
5.1.7.4.1 Services TMA market estimates and forecast, 2017 - 2028 (USD Million)
5.1.8 Others
5.1.8.1 Others market estimates and forecast, 2017 - 2028 (USD Million)
5.1.8.2 Instruments
5.1.8.2.1 Instruments others market estimates and forecast, 2017 - 2028 (USD Million)
5.1.8.3 Reagents
5.1.8.3.1 Reagents others market estimates and forecast, 2017 - 2028 (USD Million)
5.1.8.4 Services
5.1.8.4.1 Services market estimates and forecast, 2017 - 2028 (USD Million)
Chapter 6 End-use Business Analysis
6.1 Molecular Diagnostics Market: End-use Movement Analysis
6.1.1 Hospitals
6.1.1.1 Hospitals market estimates and forecast, 2017 - 2028 (USD Million)
6.1.2 Clinics
6.1.2.1 Clinics market estimates and forecast, 2017 - 2028 (USD Million)
6.1.3 Diagnostic laboratories
6.1.3.1 Diagnostic laboratories market estimates and forecast, 2017 - 2028 (USD Million)
6.1.4 Research Institutes
6.1.4.1 Research Institutes market estimates and forecast, 2017 - 2028 (USD Million)
Chapter 7 Application Business Analysis
7.1 Molecular Diagnostics Market: Application Movement Analysis
7.1.1 Respiratory Diseases
7.1.1.1 Respiratory diseases market estimates and forecast, 2017 - 2028 (USD Million)
7.1.2 Tuberculosis
7.1.2.1 Tuberculosis market estimates and forecast, 2017 - 2028 (USD Million)
7.1.3 Meningitis
7.1.3.1 Meningitis market estimates and forecast, 2017 - 2028 (USD Million)
7.1.4 Gastrointestinal Tract Infections
7.1.4.1 Gastrointestinal tract infections market estimates and forecast, 2017 - 2028 (USD Million)
7.1.5 HPV
7.1.5.1 HPV market estimates and forecast, 2017 - 2028 (USD Million)
7.1.6 Sexually Transmitted Infections
7.1.6.1 Sexually transmitted infections market estimates and forecast, 2017 - 2028 (USD Million)
7.1.7 Sepsis
7.1.7.1 Sepsis market estimates and forecast, 2017 - 2028 (USD Million)
7.1.8 Drug Resistance Disease
7.1.8.1 Drug resistance disease market estimates and forecast, 2017 - 2028 (USD Million)
7.1.9 Other Infectious Diseases
7.1.9.1 Other infectious diseases market estimates and forecast, 2017 - 2028 (USD Million)
Chapter 8 Respiratory Diseases Molecular Diagnostics Market Analysis, 2017 - 2028, (USD Million)
8.1 Product Movement Analysis & Market Share, 2020 & 2028
8.1.1 Instruments
8.1.2 Reagents
8.1.3 Services
8.2 End-use Movement Analysis & Market Share, 2020 & 2028
8.2.1 Hospitals
8.2.2 Clinics
8.2.3 Diagnostic Laboratories
8.2.4 Research Institutes
8.3 Technology Movement Analysis & Market Share, 2020 & 2028 (Number of Tests Performed)
8.3.1 Polymerase Chain Reaction (PCR)
8.3.2 In Situ Hybridization
8.3.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.3.4 Chips and Microarrays
8.3.5 Mass Spectrometry
8.3.6 Sequencing
8.3.7 Transcription Mediated Amplification
8.3.8 Others
Chapter 9 Tuberculosis-Molecular Diagnostics Market Analysis, 2017 - 2028, (USD Million)
9.1 Product Movement Analysis & Market Share, 2020 & 2028
9.1.1 Instruments
9.1.2 Reagents
9.1.3 Services
9.2 End-use Movement Analysis & Market Share, 2020 & 2028
9.2.1 Hospitals
9.2.2 Clinics
9.2.3 Diagnostic Laboratories
9.2.4 Research Institutes
9.3 Technology Movement Analysis & Market Share, 2020 & 2028 (Number of Tests Performed)
9.3.1 Polymerase Chain Reaction (PCR)
9.3.2 In Situ Hybridization
9.3.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
9.3.4 Chips and Microarrays
9.3.5 Mass Spectrometry
9.3.6 Sequencing
9.3.7 Transcription Mediated Amplification
9.3.8 Others
Chapter 10 Meningitis-Molecular Diagnostics Market Analysis, 2017 - 2028, (USD Million)
10.1 Product Movement Analysis & Market Share, 2020 & 2028
10.1.1 Instruments
10.1.2 Reagents
10.1.3 Services
10.2 End-use Movement Analysis & Market Share, 2020 & 2028
10.2.1 Hospitals
10.2.2 Clinics
10.2.3 Diagnostic Laboratories
10.2.4 Research Institutes
10.3 Technology Movement Analysis & Market Share, 2020 & 2028 (Number of Tests Performed)
10.3.1 Polymerase Chain Reaction (PCR)
10.3.2 In Situ Hybridization
10.3.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
10.3.4 Chips and Microarrays
10.3.5 Mass Spectrometry
10.3.6 Sequencing
10.3.7 Transcription Mediated Amplification
10.3.8 Others
Chapter 11 Gastrointestinal Tract Infections-Molecular Diagnostics Market Analysis, 2017- 2028, (USD Million)
11.1 Product Movement Analysis & Market Share, 2020 & 2028
11.1.1 Instruments
11.1.2 Reagents
11.1.3 Services
11.2 End-use Movement Analysis & Market Share, 2020 & 2028
11.2.1 Hospitals
11.2.2 Clinics
11.2.3 Diagnostic Laboratories
11.2.4 Research Institutes
11.3 Technology Movement Analysis & Market Share, 2020 & 2028 (Number of Tests Performed)
11.3.1 Polymerase Chain Reaction (PCR)
11.3.2 In Situ Hybridization
11.3.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
11.3.4 Chips and Microarrays
11.3.5 Mass Spectrometry
11.3.6 Sequencing
11.3.7 Transcription Mediated Amplification
11.3.8 Others
Chapter 12 HPV-Molecular Diagnostics Market Analysis, 2017 - 2028, (USD Million)
12.1 Product Movement Analysis & Market Share, 2020 & 2028
12.1.1 Instruments
12.1.2 Reagents
12.1.3 Services
12.2 End-use Movement Analysis & Market Share, 2020 & 2028
12.2.1 Hospitals
12.2.2 Clinics
12.2.3 Diagnostic Laboratories
12.2.4 Research Institutes
12.3 Technology Movement Analysis & Market Share, 2020 & 2028 (Number of Tests Performed)
12.3.1 Polymerase Chain Reaction (PCR)
12.3.2 In Situ Hybridization
12.3.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
12.3.4 Chips and Microarrays
12.3.5 Mass Spectrometry
12.3.6 Sequencing
12.3.7 Transcription Mediated Amplification
12.3.8 Others
Chapter 13 Sexually Transmitted Infections-Molecular Diagnostics Market Analysis, 2017- 2028, (USD Million)
13.1 Product Movement Analysis & Market Share, 2020 & 2028
13.1.1 Instruments
13.1.2 Reagents
13.1.3 Services
13.2 End-use Movement Analysis & Market Share, 2020 & 2028
13.2.1 Hospitals
13.2.2 Clinics
13.2.3 Diagnostic Laboratories
13.2.4 Research Institutes
13.3 Technology Movement Analysis & Market Share, 2020 & 2028 (Number of Tests Performed)
13.3.1 Polymerase Chain Reaction (PCR)
13.3.2 In Situ Hybridization
13.3.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
13.3.4 Chips and Microarrays
13.3.5 Mass Spectrometry
13.3.6 Sequencing
13.3.7 Transcription Mediated Amplification
13.3.8 Others
Chapter 14 Sepsis-Molecular Diagnostics Market Analysis, 2017 - 2028, (USD Million)
14.1 Product Movement Analysis & Market Share, 2020 & 2028
14.1.1 Instruments
14.1.2 Reagents
14.1.3 Services
14.2 End-use Movement Analysis & Market Share, 2020 & 2028
14.2.1 Hospitals
14.2.2 Clinics
14.2.3 Diagnostic Laboratories
14.2.4 Research Institutes
14.3 Technology Movement Analysis & Market Share, 2020 & 2028 (Number of Tests Performed)
14.3.1 Polymerase Chain Reaction (PCR)
14.3.2 In Situ Hybridization
14.3.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
14.3.4 Chips and Microarrays
14.3.5 Mass Spectrometry
14.3.6 Sequencing
14.3.7 Transcription Mediated Amplification
14.3.8 Others
Chapter 15 Drug Resistance Infections-Molecular Diagnostics Market Analysis, 2017 - 2028, (USD Million)
15.1 Product Movement Analysis & Market Share, 2020 & 2028
15.1.1 Instruments
15.1.2 Reagents
15.1.3 Services
15.2 End-use Movement Analysis & Market Share, 2020 & 2028
15.2.1 Hospitals
15.2.2 Clinics
15.2.3 Diagnostic Laboratories
15.2.4 Research Institutes
15.3 Technology Movement Analysis & Market Share, 2020 & 2028 (Number of Tests Performed)
15.3.1 Polymerase Chain Reaction (PCR)
15.3.2 In Situ Hybridization
15.3.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
15.3.4 Chips and Microarrays
15.3.5 Mass Spectrometry
15.3.6 Sequencing
15.3.7 Transcription Mediated Amplification
15.3.8 Others
Chapter 16 Infectious Disease Molecular Diagnostics Market: Regional Market Analysis, 2017 - 2028 (USD Million)
16.1 Definition & Scope
16.2 Regional Market Share Analysis, 2020 & 2028
16.3 Regional Market Dashboard
16.4 Regional Market Snapshot
16.5 Market Size, & Forecasts, Trend Analysis, 2020 to 2028
16.6 North America
16.6.1 North America Market estimates and forecast, 2017 - 2028 (USD Million)
16.6.2 U.S.
16.6.2.1 U.S. Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.6.3 Canada
16.6.3.1 Canada Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.7 Europe
16.7.1 Europe Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.7.2 U.K.
16.7.2.1 U.K. Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.7.3 Germany
16.7.3.1 Germany Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.7.4 Spain
16.7.4.1 Spain Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.7.5 France
16.7.5.1 France Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.7.6 Italy
16.7.6.1 Italy Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.8 Asia Pacific
16.8.1 Asia Pacific Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.8.2 Japan
16.8.2.1 Japan Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.8.3 China
16.8.3.1 China Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.8.4 India
16.8.4.1 India Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.8.5 South Korea
16.8.5.1 South Korea Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.8.6 Australia
16.8.6.1 Australia Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.9 Latin America
16.9.1 Latin America Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.9.2 Brazil
16.9.2.1 Brazil Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.9.3 Mexico
16.9.3.1 Mexico Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.9.4 Argentina
16.9.4.1 Argentina Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.10 MEA
16.10.1 MEA Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.10.2 South Africa
16.10.2.1 South Africa Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.10.3 Saudi Arabia
16.10.3.1 Saudi Arabia Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.10.4 UAE
16.10.4.1 UAE Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
Chapter 17 COMPETITIVE LANDSCAPE
17.1 Recent Developments and Impact Analysis, by Key Market Participants
17.1.1 Ansoff matrix
17.2 Company Categorization
17.2.1 Innovators
17.2.2 Market Leaders
17.3 Vendor Landscape
17.3.1 List of key distributors and channel partners
17.3.2 Key customers
17.4 Public Companies
17.4.1 Company market position analysis
17.4.2 Competitive Dashboard Analysis
17.4.2.1 Market Differentiators
17.5 Private Companies
17.5.1 List of key emerging companies
17.6 Company Profiles
17.6.1 Abbott
17.6.1.1 Company overview
17.6.1.2 Alere, Inc.
17.6.1.3 Financial performance
17.6.1.4 Product benchmarking
17.6.1.5 Strategic initiatives
17.6.2 Becton, Dickinson and Company
17.6.2.1 Company overview
17.6.2.2 Financial performance
17.6.2.3 Product benchmarking
17.6.2.4 Strategic initiatives
17.6.3 bioMérieux SA
17.6.3.1 Company overview
17.6.3.2 Financial performance
17.6.3.3 Product benchmarking
17.6.3.4 Strategic initiatives
17.6.4 Bio-Rad Laboratories, Inc.
17.6.4.1 Company overview
17.6.4.2 Financial performance
17.6.4.3 Product benchmarking
17.6.4.4 Strategic initiatives
17.6.5 Agilent Technologies, Inc.
17.6.5.1 Company overview
17.6.5.2 Financial performance
17.6.5.3 Product benchmarking
17.6.5.4 Strategic initiatives
17.6.6 Danaher Corporation
17.6.6.1 Company overview
17.6.6.2 Cepheid
17.6.6.3 Beckman Coulter
17.6.6.4 Leica Biosystems
17.6.6.5 Financial performance
17.6.6.6 Product benchmarking
17.6.6.7 Strategic initiatives
17.6.6.8 Strategic initiatives of Cepheid
17.6.7 Hologic, Inc. (Gen Probe)
17.6.7.1 Company overview
17.6.7.2 Financial performance
17.6.7.3 Product benchmarking
17.6.7.4 Strategic initiatives
17.6.8 Illumina, Inc.
17.6.8.1 Company overview
17.6.8.2 Financial performance
17.6.8.3 Product benchmarking
17.6.8.4 Strategic initiatives
17.6.9 GRIFOLs S.A.
17.6.9.1 Company overview
17.6.9.2 Financial performance
17.6.9.3 Product benchmarking
17.6.9.4 Strategic initiatives
17.6.10 Qiagen
17.6.10.1 Company overview
17.6.10.2 Financial performance
17.6.10.3 Product benchmarking
17.6.10.4 Strategic initiatives
17.6.11 F. Hoffmann-La Roche Ltd
17.6.11.1 Company overview
17.6.11.2 Financial performance
17.6.11.3 Product benchmarking
17.6.11.4 Strategic initiatives
17.6.12 Siemens Healthineers
17.6.12.1 Company overview
17.6.12.2 Financial performance
17.6.12.3 Product benchmarking
17.6.12.4 Strategic initiatives
17.6.13 Sysmex Corporation
17.6.13.1 Company overview
17.6.13.2 Financial performance
17.6.13.3 Product benchmarking
17.6.13.4 Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Regulatory Framework
Table 4 Global Infectious Disease Molecular Diagnostics Market, By Region, 2017 - 2028 (USD Million)
Table 5 Global Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
Table 6 Global Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
Table 7 Global Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
Table 8 Global Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
Table 9 Global Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
Table 10 Global Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
Table 11 Global Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
Table 12 Global Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
Table 13 Global Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
Table 14 Global Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
Table 15 Global Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
Table 16 Global Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
Table 17 North America Infectious Disease Molecular Diagnostics Market, By Country, 2017 - 2028 (USD Million)
Table 18 North America Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
Table 19 North America Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
Table 20 North America Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
Table 21 North America Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
Table 22 North America Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
Table 23 North America Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
Table 24 North America Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
Table 25 North America Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)

Companies Mentioned

  • Abbott
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • Hologic, Inc. (Gen Probe)
  • Illumina, Inc.
  • GRIFOLs S.A.
  • Qiagen
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers
  • Sysmex Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages169
PublishedSeptember 2021
Forecast Period2020 - 2028
Estimated Market Value ( USD ) in 2020 $ 32.4 Billion
Forecasted Market Value ( USD ) by 2028 $ 40.8 Billion
Compound Annual Growth Rate2.9%
Regions CoveredGlobal
No. of Companies Mentioned13

Related Topics

Related Reports

Global Molecular Diagnostics Market Size, Share & Trends Analysis Report by Product (Reagents, Instruments), Technology (PCR, INAAT), Application (Oncology, Genetic Testing), Test Location, and Segment Forecasts, 2024-2030 - Product Image

Global Molecular Diagnostics Market Size, Share & Trends Analysis Report by Product (Reagents, Instruments), Technology (PCR, INAAT), Application (Oncology, Genetic Testing), Test Location, and Segment Forecasts, 2024-2030

  • Report
  • 270 Pages
  • Global
From
Molecular Diagnostics Market by Product & Service (Reagents, Kits), Test Type (Lab, PoC), Sample Type (Blood, Urine), Technology (PCR, INAAT), Application (Infectious, Oncology), End User (Diagnostic Labs, Hospitals), Region - Global Forecast to 2028 - Product Image

Molecular Diagnostics Market by Product & Service (Reagents, Kits), Test Type (Lab, PoC), Sample Type (Blood, Urine), Technology (PCR, INAAT), Application (Infectious, Oncology), End User (Diagnostic Labs, Hospitals), Region - Global Forecast to 2028

  • Report
  • 310 Pages
  • Global
From
Global Point-of-Care (PoC) Molecular Diagnostics Market by Product (Assays, Kits, Instruments, Software), Application (Respiratory Diseases, HAIs, Cancer, STDs, Hepatitis), Technology (RT-PCR, INAAT), End-user (Clinics, Hospitals, ICUs), and Region - Forecast to 2028 - Product Image

Global Point-of-Care (PoC) Molecular Diagnostics Market by Product (Assays, Kits, Instruments, Software), Application (Respiratory Diseases, HAIs, Cancer, STDs, Hepatitis), Technology (RT-PCR, INAAT), End-user (Clinics, Hospitals, ICUs), and Region - Forecast to 2028

  • Report
  • 207 Pages
  • Global
From
Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2024 - Product Image

Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Molecular Diagnostic Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology), End User (Hospital, Diagnostic Lab) - Global Forecast to 2030 - Product Image

Molecular Diagnostic Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology), End User (Hospital, Diagnostic Lab) - Global Forecast to 2030

  • Report
  • 327 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.